• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Esophageal and small bowel obstruction from guar gum-containing "diet pills": analysis of 26 cases reported to the Food and Drug Administration.

作者信息

Lewis J H

机构信息

Division of Gastroenterology, Georgetown University Hospital, Washington, DC.

出版信息

Am J Gastroenterol. 1992 Oct;87(10):1424-8.

PMID:1329494
Abstract

Twenty-six domestic reports of suspected adverse reactions from the guar gum-containing diet pill, Cal-Ban 3000 (filed with the FDA) were reviewed. There were 18 instances of esophageal obstruction, seven instances of small bowel obstruction, and one individual who was reported to have died after ingestion of Cal-Ban 3000, but for whom insufficient details were provided to assess causation. There were 14 women and 11 men (mean age 46.3 yr; range 17 to 67 yr) for whom sufficient information was available. Preexisting esophageal or gastric disorders were present in 50% of those with esophageal obstruction, including peptic stricture, pyrosis, hiatal hernia, esophagitis, gastric stapling procedure, Schatzki ring, and muscular dystrophy. Fourteen of these 18 patients with esophageal obstruction were treated successfully by endoscopy, although the tenacious gel-like consistency of the material was often difficult to remove. Two patients required rigid esophagoscopy when flexible endoscopy was unsuccessful. This resulted in the death of one patient who developed a pulmonary embolism after surgical repair of an intraoperative esophageal tear. For the seven patients with small bowel obstruction, no specific predisposing factors were mentioned. One individual required exploratory laparotomy, and inspissated tablets were found in the ileum. These cases, spontaneously reported to the FDA, are very similar to those reported in the literature. The water-holding capacity and gel-forming tendency of guar gum permits it to swell in size 10- to 20-fold, and may lead to luminal obstruction, especially when an anatomic predisposition exists. Such products have been banned in Australia, and Cal-Ban 3000 has recently been removed from the market in the United States. However, unsuspecting patients who are still in possession of the product should be apprised of the potential complications that may arise with its use.

摘要

相似文献

1
Esophageal and small bowel obstruction from guar gum-containing "diet pills": analysis of 26 cases reported to the Food and Drug Administration.
Am J Gastroenterol. 1992 Oct;87(10):1424-8.
2
[Bolus obstruction of the distal esophagus caused by hydrophilic plant material (guar gum)].[亲水性植物材料(瓜尔豆胶)引起的食管远端团块梗阻]
Dtsch Med Wochenschr. 1983 Dec 23;108(51-52):1968-9. doi: 10.1055/s-2008-1069859.
3
Distal esophageal obstruction due to a guar gum preparation (Cal-Ban 3000).
South Med J. 1992 Jun;85(6):642-5. doi: 10.1097/00007611-199206000-00015.
4
National adverse drug event reporting.国家药品不良事件报告。
Am J Hosp Pharm. 1993 Sep;50(9):1913-4.
5
Esophageal obstruction caused by Cal-Ban.
Gastroenterology. 1990 Mar;98(3):805-6. doi: 10.1016/0016-5085(90)90314-q.
6
Esophageal obstruction with a dietary fiber product designed for weight reduction.食用一种专为减肥设计的膳食纤维产品导致食管梗阻。
J Clin Gastroenterol. 1990 Dec;12(6):667-9. doi: 10.1097/00004836-199012000-00014.
7
Guar gum is not a panacea in diabetes management.瓜尔豆胶并非糖尿病管理的万灵药。
N Z Med J. 1981 May 13;93(683):292-4.
8
[The use of guar gum in treating hypercholesterolemia].[瓜尔豆胶在治疗高胆固醇血症中的应用]
Ter Arkh. 1991;63(8):70-2.
9
Adverse effects of soluble non-starch polysaccharide (guar gum) on piglet growth and experimental colibacillosis immediately after weaning.断奶后即刻,可溶性非淀粉多糖(瓜尔胶)对仔猪生长及实验性大肠杆菌病的不良影响。
Res Vet Sci. 1999 Dec;67(3):245-50. doi: 10.1053/rvsc.1999.0315.
10
Guar gum as a carrier for colon specific delivery; influence of metronidazole and tinidazole on in vitro release of albendazole from guar gum matrix tablets.瓜尔胶作为结肠特定给药的载体;甲硝唑和替硝唑对阿苯达唑从瓜尔胶基质片中体外释放的影响。
J Pharm Pharm Sci. 2001 Sep-Dec;4(3):235-43.

引用本文的文献

1
Re-evaluation of guar gum (E 412) as a food additive.对瓜尔胶(E 412)作为食品添加剂的重新评估。
EFSA J. 2017 Feb 24;15(2):e04669. doi: 10.2903/j.efsa.2017.4669. eCollection 2017 Feb.
2
Re-evaluation of locust bean gum (E 410) as a food additive.刺槐豆胶(E 410)作为食品添加剂的重新评估。
EFSA J. 2017 Jan 20;15(1):e04646. doi: 10.2903/j.efsa.2017.4646. eCollection 2017 Jan.
3
Esophageal bezoar due to karaya gum granules used as a laxative.因使用卡拉亚树胶颗粒作为泻药导致的食管粪石。
Clin J Gastroenterol. 2017 Oct;10(5):437-441. doi: 10.1007/s12328-017-0764-x. Epub 2017 Jul 20.
4
Toxicity of weight loss agents.减肥药物的毒性。
J Med Toxicol. 2012 Jun;8(2):145-52. doi: 10.1007/s13181-012-0213-7.
5
Dose-dependent effects, safety and tolerability of fenugreek in diet-induced metabolic disorders in rats.剂量依赖性效应、安全性和耐受性的胡芦巴在饮食诱导的代谢紊乱的大鼠。
Lipids Health Dis. 2011 Dec 21;10:240. doi: 10.1186/1476-511X-10-240.
6
Suspected adverse reactions associated with herbal products used for weight loss: a case series reported to the Italian National Institute of Health.怀疑与用于减肥的草药产品相关的不良反应:向意大利国家卫生研究所报告的一系列病例。
Eur J Clin Pharmacol. 2011 Mar;67(3):215-24. doi: 10.1007/s00228-010-0981-4. Epub 2011 Jan 18.
7
Herbal supplements: considerations for the athletic trainer.草药补充剂:运动训练师的注意事项。
J Athl Train. 2001 Oct;36(4):425-32.
8
Pill Esophagitis.药丸性食管炎
Curr Treat Options Gastroenterol. 2004 Feb;7(1):71-76. doi: 10.1007/s11938-004-0027-z.
9
Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study.一种缓释、不可变形口服剂型(OROS)的胃肠道安全性:一项回顾性研究
Drug Saf. 2002;25(14):1021-33. doi: 10.2165/00002018-200225140-00004.